NCT01119534UnknownPhase 3
Comparative Efficacy of the Suppository Composed by Guaiacol, Eucalyptol, Menthol and Camphor Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Sponsor
- Azidus Brasil
- Enrollment
- 270
- Locations
- 1
- Primary Endpoint
- Improvement of cough of infectious origin.
Study Overview
Brief Summary
It is believed that the suppository consisting of guaiacol, menthol, camphor and eucalyptol, by their pharmacological properties already established for each component, has the ability to reduce the signs and symptoms related to upper respiratory infections in a manner equivalent (not inferior) to medicine used as a comparator in this study and higher than the suppository containing only guaiacol concentration of 12.5 mg.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 2 Years to 6 Years (Child)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients that parents or legal guardians agree to their participation in the study and agree on the terms proposed in the IC, signing it;
- •Patients aged ≥ (greater than or equal to) 02 years and ≤ (less than or equal to) 6 years, 11 months and 29 days, of any ethnicity, class or social group.
- •Patients with acute respiratory disease of upper respiratory viral diseases (URI);
- •Patients with productive cough;
- •Clinical picture of URI defined by the doctor that started less than 48 hours.
Exclusion Criteria
- •Patients being treated with antibiotics;
- •Presence of clinical features of bacterial infection of the upper airways and / or pulmonary (acute bacterial sinusitis, pneumonia, etc.).
- •Patients with non-productive cough;
- •Treatment with immunosuppressive drugs;
- •Presence of any medical condition that, according to the investigator, should prevent the patient from the study;
- •Participation in clinical trials in the 12 months preceding the study, according to Resolution 251 (ANVISA), August 7, 1997, item III, sub-item J;
- •Patients with serious diseases;
- •Patients who require multidrug treatment;
- •Presence of other concomitant pulmonary diseases
- •History of hypersensitivity to drugs of the same pharmacological classes of substances under investigation;
- •Patients with diseases that interfere with lung function, such as cerebral palsy or muscular atrophies;
- •Patients under medication or supplement (eg physiotherapy) that may interfere with the cough;
- •Patients with severe dysfunction of the hepatorenal function;
- •Patients with x-ray of the chest or sinus compatible with picture of bacterial infection;
- •Patients with blood cell count suggestive of bacterial infection;
- •Changes in laboratory, clinical, physical and / or radiological agents that, judged by investigators, could compromise patient health or reliability of the data.
Arms & Interventions
Transpulmin
Experimental
Suppository composed by guaiacol, eucalyptol, menthol and camphor
Intervention: Guaiacol, eucalyptol, menthol and camphor suppository (Drug)
Comparator 1
Active Comparator
Suppository composed by guaiacol
Intervention: guaiacol suppository (Drug)
Comparator 2
Active Comparator
Syrup composed by guaifenesin
Intervention: Guaifenesin syrup (Drug)
Outcomes
Primary Outcomes
Improvement of cough of infectious origin.
Time Frame: 7 days of treatment.
During visits (V1, V2, V3 and V4) will be assessed the signs of improvement of cough of infectious origin.
Secondary Outcomes
- Analysis of parameters for the improvement of infectious cough.(7 days of treatment.)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal CandidiasisVulvovaginal Candidiasis, GenitalNCT06411314Avva Rus, JSC218
Completed
Phase 2
Efficacy of Captophyte compound in comparison with Captopril alone on blood pressure in patients with essential hypertensioEssential Hypertesion.Essential (primary) hypertensionIRCT2015020110326N2Vice Chancellor for Research & Technology, Hormozgan University of Medical Sciences50
Recruiting
Not Applicable
Comparison of the effectiveness of 2 substances articaine and mepivacaine on palatal Anesthesia by posterior superior alveolar nerve block on posterior of maxillaRemoval of posterior maxillary teeth.IRCT20170307032929N5Islamic Azad University20
Completed
Phase 4
Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and PlaceboCough Reflex SensitivityNCT02062710Montefiore Medical Center22
Completed
Phase 1
Evaluation of Effect of glycerin suppository in prevention of neonatal jaundice in besat hospital in sanandaj in 2016-17IRCT20180306038980N1Sanandaj University of Medical Sciences220